Hepion Pharmaceuticals Inc (HEPA)

Currency in USD
0.115
+0.014(+13.64%)
Closed·
HEPA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.1050.135
52 wk Range
0.0340.220
Key Statistics
Prev. Close
0.101
Open
0.11
Day's Range
0.105-0.135
52 wk Range
0.034-0.22
Volume
32.94K
Average Volume (3m)
39K
1-Year Change
61.9718%
Book Value / Share
-0,014
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HEPA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Hepion Pharmaceuticals Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Earnings

Latest Release
Aug 13, 2026
EPS / Forecast
-0,08 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

HEPA Income Statement

Compare HEPA to Peers and Sector

Metrics to compare
HEPA
Peers
Sector
Relationship
P/E Ratio
−3.1x−5.2x−0.2x
PEG Ratio
−0.03−0.170.00
Price/Book
−23.8x0.0x2.6x
Price / LTM Sales
-3.9x2.7x
Upside (Analyst Target)
-130.2%66.0%
Fair Value Upside
Unlock17.3%10.8%Unlock

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States. It developed Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation; liver tumor burden; and titers of HBV, HCV, and HDV. It also operates as a biotech research development company. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Morristown, New Jersey.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0,000,00%0,00
Other Institutional Investors
53,50M54,47%5,41M
Public Companies & Retail Investors
44,72M45,53%4,53M
Total
98,22M100,00%9,94M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Gravitas Collective Corp.25,45%25 000 0002 530
Gravitas Capital LP14,51%14 250 0001 442

FAQ

What Is the Hepion Pharmaceuticals (HEPA) Stock Price Today?

The Hepion Pharmaceuticals stock price today is 0,115 USD.

What Stock Exchange Does Hepion Pharmaceuticals Trade On?

Hepion Pharmaceuticals is listed and trades on the OTC Markets.

What Is the Stock Symbol for Hepion Pharmaceuticals?

The stock symbol for Hepion Pharmaceuticals is "HEPA."

What Is the Hepion Pharmaceuticals Market Cap?

As of today, Hepion Pharmaceuticals market cap is 9,940M USD.

What Is Hepion Pharmaceuticals's Earnings Per Share (TTM)?

The Hepion Pharmaceuticals EPS (TTM) is -0,25.

From a Technical Analysis Perspective, Is HEPA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Hepion Pharmaceuticals Stock Split?

Hepion Pharmaceuticals has split 4 times.

How Many Employees Does Hepion Pharmaceuticals Have?

Hepion Pharmaceuticals has 2 employees.

What is the current trading status of Hepion Pharmaceuticals (HEPA)?

As of Nov 17, 2026, Hepion Pharmaceuticals (HEPA) is trading at a price of 0,115 USD, with a previous close of 0,101 USD. The stock has fluctuated within a day range of 0,105 USD to 0,135 USD, while its 52-week range spans from 0,034 USD to 0,220 USD.

What Is the HEPA After Hours Price?

HEPA's last after hours stock price is 0,050 USD, the stock has decreased by -0,006, or -10,710%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.